Liaoning OxiranchemInc Future Growth
Future criteria checks 3/6
Liaoning OxiranchemInc is forecast to grow earnings and revenue by 112.5% and 12.9% per annum respectively. EPS is expected to grow by 112.4% per annum. Return on equity is forecast to be 5.1% in 3 years.
Key information
112.5%
Earnings growth rate
112.4%
EPS growth rate
Chemicals earnings growth | 33.5% |
Revenue growth rate | 12.9% |
Future return on equity | 5.1% |
Analyst coverage | Low |
Last updated | 19 Aug 2024 |
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 5,087 | 215 | N/A | 466 | 2 |
12/31/2025 | 4,727 | 122 | N/A | 295 | 2 |
12/31/2024 | 4,172 | 9 | N/A | 195 | 2 |
6/30/2024 | 3,609 | -260 | -394 | -363 | N/A |
3/31/2024 | 3,632 | -327 | -191 | -154 | N/A |
12/31/2023 | 3,813 | -309 | 17 | 87 | N/A |
9/30/2023 | 4,254 | -197 | 22 | 217 | N/A |
6/30/2023 | 4,760 | -192 | 95 | 305 | N/A |
3/31/2023 | 5,237 | -154 | 184 | 400 | N/A |
1/1/2023 | 5,639 | 6 | 48 | 306 | N/A |
9/30/2022 | 6,103 | 168 | 236 | 495 | N/A |
6/30/2022 | 6,520 | 317 | 96 | 357 | N/A |
3/31/2022 | 6,675 | 401 | 331 | 568 | N/A |
1/1/2022 | 6,717 | 352 | 10 | 497 | N/A |
9/30/2021 | 6,785 | 291 | -278 | 270 | N/A |
6/30/2021 | 6,470 | 345 | -174 | 497 | N/A |
3/31/2021 | 6,336 | 440 | -152 | 535 | N/A |
12/31/2020 | 5,708 | 403 | 257 | 623 | N/A |
9/30/2020 | 5,719 | 415 | 446 | 696 | N/A |
6/30/2020 | 5,758 | 361 | 732 | 844 | N/A |
3/31/2020 | 5,697 | 308 | 695 | 805 | N/A |
12/31/2019 | 6,389 | 352 | 1,178 | 1,285 | N/A |
9/30/2019 | 6,410 | 316 | 1,564 | 1,595 | N/A |
6/30/2019 | 7,098 | 333 | 1,206 | 1,236 | N/A |
3/31/2019 | 7,667 | 353 | 1,297 | 1,326 | N/A |
12/31/2018 | 7,449 | 326 | 692 | 720 | N/A |
9/30/2018 | 7,421 | 304 | 9 | 83 | N/A |
6/30/2018 | 6,655 | 254 | 249 | 320 | N/A |
3/31/2018 | 5,895 | 214 | N/A | 49 | N/A |
12/31/2017 | 5,699 | 209 | N/A | 139 | N/A |
9/30/2017 | 5,254 | 140 | N/A | 338 | N/A |
6/30/2017 | 4,945 | 125 | N/A | 240 | N/A |
3/31/2017 | 4,596 | 115 | N/A | 54 | N/A |
12/31/2016 | 4,347 | 76 | N/A | 216 | N/A |
9/30/2016 | 3,831 | -22 | N/A | -148 | N/A |
6/30/2016 | 3,415 | -188 | N/A | -167 | N/A |
3/31/2016 | 3,157 | -226 | N/A | 11 | N/A |
12/31/2015 | 2,965 | -210 | N/A | 1 | N/A |
9/30/2015 | 2,804 | -94 | N/A | -61 | N/A |
6/30/2015 | 2,777 | 41 | N/A | -85 | N/A |
3/31/2015 | 2,845 | 72 | N/A | -242 | N/A |
12/31/2014 | 2,883 | 92 | N/A | -475 | N/A |
9/30/2014 | 2,932 | 112 | N/A | 62 | N/A |
6/30/2014 | 2,829 | 108 | N/A | 87 | N/A |
3/31/2014 | 2,642 | 91 | N/A | 30 | N/A |
12/31/2013 | 2,494 | 81 | N/A | 112 | N/A |
9/30/2013 | 2,371 | 72 | N/A | 130 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 300082 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.9%).
Earnings vs Market: 300082 is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: 300082 is expected to become profitable in the next 3 years.
Revenue vs Market: 300082's revenue (12.9% per year) is forecast to grow slower than the CN market (13.2% per year).
High Growth Revenue: 300082's revenue (12.9% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 300082's Return on Equity is forecast to be low in 3 years time (5.1%).